News Detail
New Delhi, 26 Feb 2025: The Central Drugs Standard Control Organisation (CDSCO) has directed the state and Union Territory (UT) drug regulators to sensitise its inspectorate staff to keep strict vigil to ensure that the non-steroidal anti-inflammatory drug (NSAID) nimesulide is n......
View Details
Source : Pharmabiz
Central Drugs Standard Control Organisation
CDSCO
drug regulators
strict vigil
non-steroidal anti-inflammatory drug
NSAID
nimesulide
Union ministry of health
Delhi High Court
DTAB
ICMR
Bombay Natural History Society
BNHS
diclofenac
aceclofenac
ketoprofen
MOEF&CC
Indian Veterinary Research Institute
IVRI
Related News
- Will the Centre compensate for adverse Covid vaccine effects? SC seeks govt reply on framing policy (26-02-2025)
- Indian drugmakers to stay competitive despite US tariff plans: Dr Reddy's (26-02-2025)
- Regulatory standards must be stronger for quality medicines: Health secy (26-02-2025)
- Ensure no prescription drugs sold illegally, HC directs CBI, NCB (25-02-2025)
- Drugs & Cosmetics Act: Only Sessions Court Can Try Offences Punishable Under Chapter IV (25-02-2025)
- SC calls for mechanism under law for misleading ads complaints (25-02-2025)
- Maharashtra Medical Council Launches ‘Know Your Doctor’ Platform to Curb quackery (25-02-2025)
- 3 in 5 individuals in India die after cancer diagnosis: Study (25-02-2025)
- International Vaccine Institute launches new biorepository in South Korea (25-02-2025)
- MoU signed for inter-ministerial cooperation for promotion of 'One Herb, One Standard' (25-02-2025)